Intraventricular Hemorrhage and White Matter Injury in Preclinical and Clinical Studies

Area of Science:

• Neonatal neurology
• Pediatric neurosurgery
• Developmental neuroscience

Background:

• Germinal matrix-intraventricular hemorrhage (IVH) affects nearly half of infants born before 26 weeks' gestation.
• Survivors face high risks of cerebral palsy, cognitive deficits, and other neurological sequelae.
• Secondary brain injury mechanisms include inflammation, blood component toxicity, and impaired blood-brain barrier function.

Purpose of the Study:

• To systematically review preclinical and clinical studies on IVH-induced brain injury.
• To identify potential targets for enhancing brain repair after IVH.
• To highlight research gaps and prioritize interventions for future clinical trials.

Main Methods:

• Systematic literature review of animal models and human studies on IVH.
• Analysis of mechanisms including inflammation, glial activation, and blood-brain barrier integrity.
• Evaluation of reported preclinical targets and clinical intervention effectiveness.

Main Results:

• Animal models have explored IVH causes and repair targets.
• Preclinical studies identified potential therapeutic targets.
• Limited data exists on the clinical effectiveness of interventions for IVH-induced brain injury.

Conclusions:

• Further research is needed to bridge the gap between preclinical findings and clinical application for IVH.
• Systematic reviews can guide the development of effective treatments for IVH.
• Future clinical trials must focus on robust, long-term outcome reporting.